NDC 51672-4074-01 - Hydrocortisone Butyrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4074
- Requested NDC
- 51672-4074-01
- Package NDCs from labels
- 51672-4074-5, 51672-4074-7, 51672-4074-1, 51672-4074-2, 51672-4074-6, 51672-4074-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocortisone Butyrate Ointment, 0.1% Hydrocortisone Butyrate Cream USP, 0.1% Hydrocortisone Butyrate Topical Solution, 0.1% | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4074-1 | Hydrocortisone Butyrate | 1 in 1 CARTON | CREAM | 1 | 5 | |
| 51672-4074-1 | Hydrocortisone Butyrate | 15 g in 1 TUBE | CREAM | 15 | 5 | |
| 51672-4074-2 | Hydrocortisone Butyrate | 30 g in 1 TUBE | CREAM | 30 | 5 | |
| 51672-4074-2 | Hydrocortisone Butyrate | 1 in 1 CARTON | CREAM | 1 | 5 | |
| 51672-4074-5 | Hydrocortisone Butyrate | 5 g in 1 TUBE | CREAM | 5 | 5 | |
| 51672-4074-6 | Hydrocortisone Butyrate | 45 g in 1 TUBE | CREAM | 45 | 5 | |
| 51672-4074-6 | Hydrocortisone Butyrate | 1 in 1 CARTON | CREAM | 1 | 5 | |
| 51672-4074-7 | Hydrocortisone Butyrate | 1 in 1 CARTON | CREAM | 1 | 5 | |
| 51672-4074-7 | Hydrocortisone Butyrate | 10 g in 1 TUBE | CREAM | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4074 | HYDROCORTISONE BUTYRATE SOLUTION HYDROCORTISONE BUTYRATE CREAM HYDROCORTISONE BUTYRATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 9 package rows | 20210409_51176835-598d-4da7-8a00-6bd36f52aa82.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4074-1 | GM - Gram | 51672-4074 | e175c1af-8333-4d53-bdc8-9d48bb0de46f | 1 | 2012-07-24 |
| 51672-4074-6 | GM - Gram | 51672-4074 | 4eeceb59-6e4f-4111-8f59-ee88a7b420e9 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alcohol Prep Pads | 70%ISOPROPYL ALCOHOL | Raya Pharmaceuticals LLC | da108e12-4327-db1c-e053-2a95a90a211b | 2023-10-27 | Warnings | ND2M416302 |
| Family Wellness | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, PETROLATUM | FRONT PHARMACEUTICAL PLC | eb1785f4-5876-443b-b175-9b59d65d1a48 | 2023-10-26 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| CVS Health Hemorrhoidal Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | FRONT PHARMACEUTICAL PLC | cb448d78-553c-4e65-80c5-d4b31d7b3661 | 2023-10-26 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| FLEET | MINERAL OIL | C.B. Fleet Company, Inc. | 2528cb5e-437e-41f0-9c34-e9ce57404d8b | 2023-10-26 | Warnings | T5L8T28FGP |
| Family Wellness | PHENYLEPHRINE HCL, PETROLATUM, MINERAL | Zhejiang Jingwei Pharmaceutical Co., Ltd. | bfa195d7-d87f-43b5-bbf1-7ec3a451de05 | 2023-10-25 | Warnings | 4T6H12BN9U T5L8T28FGP |
| TheraPlus Plus | PHENYLEPHRINE HCI | Zhejiang Jingwei Pharmaceutical Co., Ltd. | edf9f8d5-f55d-4c31-adfb-ba77ca24cc3d | 2023-10-25 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Hemorrhoidal Cream | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | Cardinal Health 110, LLC. dba Leader | 85a51d5c-679e-1959-e053-2a91aa0a76d5 | 2023-10-25 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| Family Wellness | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, PETROLATUM | Zhejiang Jingwei Pharmaceutical Co., Ltd. | fde9cd90-d63c-4058-b46e-511fecea36ec | 2023-10-24 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| Dr. Sayman Salve | SALVE | Sheffield Pharmaceuticals LLC | 18bdcd0c-9c81-47e1-ae24-2239ff8fd066 | 2023-10-24 | Warnings | 4T6H12BN9U |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | 4bfea435-f40d-4976-8450-a699f7640c65 | 2023-10-23 | Warnings | ND2M416302 |
| Sting Relief | BENZOCAINE, ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | 3a32398a-3f7e-4da0-bb1d-b3f369914b2a | 2023-10-23 | Warnings | ND2M416302 |
| Alcohol Prep Pad | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | 1c7f9a00-6600-4b0d-af11-fa776b22e678 | 2023-10-23 | Warnings | ND2M416302 |
| Alcohol Prep Pad | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | 1c9f2c8b-6ed6-4e54-a151-5be4acb290e4 | 2023-10-23 | Warnings | ND2M416302 |
| Alcohol Prep Pad | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | 878bfaa7-d553-40db-8311-19010930abd9 | 2023-10-23 | Warnings | ND2M416302 |
| Alcohol Prep Pad | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | c1273e40-5c09-435b-adf3-e352fdd01e9e | 2023-10-23 | Warnings | ND2M416302 |
| Alcohol Preps Sterile | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | 65c8f4de-6516-4caa-a458-228b7b4f6f78 | 2023-10-23 | Warnings | ND2M416302 |
| Alcohol Prep Pad | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | c13af96e-f76a-4577-8d57-811ccc652738 | 2023-10-23 | Warnings | ND2M416302 |
| Alcohol Prep Pad 70 Isopropyl Alcohol | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | af84e47f-01d6-d24e-e053-2a95a90a7edd | 2023-10-23 | Warnings | ND2M416302 |
| Alcohol Prep Pad Non-Sterile | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | 9b835128-194a-4527-abd5-c507ca94b197 | 2023-10-23 | Warnings | ND2M416302 |
| Alcohol Prep Pad Sterile | ISOPROPYL ALCOHOL | Jianerkang Medical Co., Ltd | a4d1f759-7f35-d277-e053-2a95a90abc8c | 2023-10-23 | Warnings | ND2M416302 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.